Safety and effectiveness evaluation of the injection transplantation method of human pacemaker cardiomyocyte derived from induced pluripotent stem cells

Q4 Medicine

Genes and Cells Pub Date : 2018-12-30 DOI:10.23868/201812044

A. Ponomarenko, E. Chepeleva, S. Pavlova, A. Romanov, A. Strelnikov, D. Sergeevichev, E. Pokushalov

引用次数: 0

查看原文本刊更多论文

诱导多能干细胞衍生人起搏器心肌细胞注射移植方法的安全性和有效性评价

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Genes and Cells Medicine-Transplantation

CiteScore

0.50

自引率

0.00%

发文量

期刊介绍： “Genes and Cells” (the old name is “Cell Transplantology and Tissue Engineering”) is a peer-reviewed scientific and practical journal recommended by the Higher Attestation Commission of the Ministry of Education and Science of the Russian Federation for publishing basic materials of dissertation research. Originally conceived as a highly specialized publication, the Journal has now gained an ever wider target audience. If at the beginning of its journey — from September 2005 — the target audience of the journal were biotechnologists, specialists in the field of molecular and cell biology, by now it has expanded with medical practitioners. Such progressive dynamics are absolutely natural — over the last 7-10 years, biomedical technologies have come out of the exotic category, lack of understanding of the inhabitants and mistrust of clinicians have been replaced by interest and awareness of the need to use biotechnology tools in medicine no longer tomorrow, but today. The sections of the journal are formulated to fully disclose the target topics of the publication, convey to readers the opinions of leading experts in the field of biomedical technologies on topical issues of concern, acquaint them with the most significant recent foreign and domestic research, materials of thematic conferences, present analytical information on fundamental issues of biomedical technologies trends in the biotech business. The journal includes the following headings: “expert opinions”, “cell technology news”, “reviews”, “original research”, “clinical experience”, “discussion and general theoretical work”, “stem cell business”.